← SynDRA
4-methoxy-N-(2,4,6-trimethylphenyl)benzenesulfonamide
SynDRA canonical compound SYN1466210 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | FFAR4 |
|---|
| Mechanism of action | free fatty acid receptor agonist |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- GSK137647A
- N-mesityl-4-methoxybenzenesulfonamide
- MFCD02007969
- GSK-137647A
- 4-methoxy-N-(2,4,6-trimethylphenyl)benzene-1-sulfonamide
- 4-methoxy-N-(2,4,6-trimethylphenyl)-benzenesulfonamide
- CBMicro_012617
- Oprea1_349531
- Oprea1_545891
- orb1304464
- SCHEMBL19357604
- GLXC-04882
- EX-A1097
- GSK37647
- SMSF0014079
- ZNA08582
- BDBM50044849
- STK899558
- AKOS003261220
- CB15818
- CS-5549
- GSK-137647
- NCGC00387253-02
- NCGC00387253-05
- AC-35329
- AS-16737
- DA-63920
- HY-19995
- BIM-0012523.P001
- FFA4 (GPR120) agonist GSK137647A
- EU-0076636
- FFA4 (GPR120) agonist GSK137647A?
- ST50719559
- GSK137647A, >=98% (HPLC)
- AJ-292/14925630
- SR-01000478738
- SR-01000478738-1
- [(4-methoxyphenyl)sulfonyl](2,4,6-trimethylphenyl)amine
Look up 4-methoxy-N-(2,4,6-trimethylphenyl)benzenesulfonamide in the interactive SynDRA portal →